- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06821841
Online Physical Activity Intervention for Peri- and Post-menopausal Working Women (RCT)
Using Psychological Theory to Promote Physical Activity Among Peri- and Post-menopausal Working Women: A Pilot Randomised-Controlled Trial (RCT).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kent
-
Royal Tunbridge Wells, Kent, United Kingdom, TN1 2YG
- Salomons Institute for Applied Psychology, Canterbury Christ Church University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female
- Aged 30-60 years
- Currently working full-time (approximately 35+ hours per week)
- Currently experiencing perimenopausal (women with newly inconsistent menstrual cycles, >1 year since last cycle) or post-menopausal (cessation of menstrual cycle for >12 months) symptoms, which are impacting functioning
- Currently physically inactive or not meeting recommended government guidelines (150-minutes of moderate-vigorous physical activity per week)
- No comorbid health conditions that impact ability to participate in physical activity
Exclusion Criteria:
- Those who do not meet the inclusion criteria.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Online Physical Activity Group
|
The online physical activity group will consist of four 45-60-minute sessions, which participants allocated to this group will be asked to commit to.
These sessions will be delivered online and occur for 4 weeks.
Discussions within the sessions will incorporate motivational interviewing, focussing on the benefits of physical activity, current physical activity levels, barriers to physical activity and overcoming these, motivation to complete physical activity, and goal setting.
Participants allocated to this group will receive weekly reminders to promote attendance.
Participants will also be asked to complete a weekly physical activity log that includes detail about the type of physical activity they completed, the duration, intensity, context and comments.
Participants will receive an information leaflet that includes information about menopause (e.g.
definition, symptoms), the benefits of physical activity for menopause, recommended weekly physical activity levels (based on CMO guidelines), examples of physical activity, and signposting to online resources.
Participants will be able to use the information leaflet as they wish, and complete a weekly physical activity log that includes detail about the type of physical activity completed, the duration, intensity, context and comments.
|
|
Other: Control - Information Leaflet Only
|
Participants will receive an information leaflet that includes information about menopause (e.g.
definition, symptoms), the benefits of physical activity for menopause, recommended weekly physical activity levels (based on CMO guidelines), examples of physical activity, and signposting to online resources.
Participants will be able to use the information leaflet as they wish, and complete a weekly physical activity log that includes detail about the type of physical activity completed, the duration, intensity, context and comments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants recruited to the study
Time Frame: 9 months from the start of recruitment
|
The number of participants recruited will be compared to pre-defined progression criteria, based on existing literature, to examine the feasibility of recruitment.
This progression criteria will follow a traffic light system; Green = 40-50 participants, Amber = >24 participants, Red = <24 participants.
|
9 months from the start of recruitment
|
|
Retention rate of participants attending the online intervention
Time Frame: Week 0 to 8-9
|
The proportion of participants who attend at least half of the online physical activity group sessions, which will be compared to progression criteria; Green = >50%, Amber = 25-49%, Red = <25%.
|
Week 0 to 8-9
|
|
The retention rate of participants who remain in the study as a whole
Time Frame: Week 0 to 12-13
|
The proportion of participants who remain in the study, compared to progression criteria: Green = >50%, Amber = 25-49%, Red = <25%
|
Week 0 to 12-13
|
|
Acceptability of the online physical activity group intervention
Time Frame: Week 8-9
|
Participant responses to the feedback questionnaire, including Likert-scale questions and content analysis of qualitative questions.
This will be compared to progression criteria; Green = High satisfaction/acceptability from the majority of participants, with a mean of 7/10 on the Likert-scale questions, Amber = Moderate/Inconsistent satisfaction and acceptability indicated, Red = Low satisfaction/acceptability from the majority of participants
|
Week 8-9
|
|
Preliminary indicator of effectiveness for the primary outcome (physical activity)
Time Frame: Week 8-9 and 12-13
|
Estimate of the between group effect size for the online physical activity group compared to control group on the International Physical Activity Questionnaire-Short Form (IPAQ-SF), from baseline [Week 0 - 1] to post-intervention and follow-up [Week 8-9 and Week 12-13, respectively]. This will be compared to progression criteria; Green = the between-group effect size is in favour of the intervention, with a substantial number of participants (>50%) showing reliable change (according to the calculated Reliable Change index; Jacobson & Truax, 1991), Amber = between-group effect size is in favour of the intervention arm, with a small number of participants showing reliable change (25-49%), Red = between-group effect size is in favour of the control group, with a minimal number of participants in the intervention group showing reliable change (<25%). For the IPAQ, greater scores indicate higher physical activity levels (better outcome). |
Week 8-9 and 12-13
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Estimate of between group effect size for change on the International Physical Activity Questionnaire-Short Form (IPAQ-SF) from baseline to post-intervention and 1-month follow-up
Time Frame: Week 8-9 and 12-13
|
Estimate of the between group effect size of the online physical activity group compared to control group on change on the International Physical Activity Questionnaire - Short Form (IPAQ-SF) from baseline (week 0-1) to post intervention (week 8-9) and follow-up (week 12-13).
The IPAQ-SF is a 7-item questionnaire that assesses an individual's physical activity levels (e.g.
walking, moderate-intensity, vigorous-intensity) and sedentary behaviour (e.g.
sitting).
Higher scores on the IPAQ-SF indicates more physical activity.
|
Week 8-9 and 12-13
|
|
Estimate of between group effect size for the Menopause Rating Scale (MRS) from baseline to post-intervention and 1-month follow-up
Time Frame: Week 8-9 and 12-13
|
Estimate of the between group effect size of the online physical activity group compared to control group on change on the Menopause Rating Scale (MRS) from baseline (week 0-1) to post-intervention (week 8-9) and follow-up (week 12-13).
The MRS is an 11-item questionnaire that assesses the severity of various menopausal symptoms (somatic, psychological and urogenital) using a 5-point Likert-scale.
Higher scores on the MRS indicate greater symptoms severity.
|
Week 8-9 and 12-13
|
|
Estimate of between group effect size for the Work Productivity and Activity Impairment Questionnaire (WPAI) from baseline to post-intervention and 1-month follow-up
Time Frame: Week 8-9 and 12-13
|
Estimate of the between group effect size of the online physical activity group compared to control group on the change on the Work Productivity and Activity Impairment Questionnaire (WPAI) from baseline (week 0-1) to post-intervention (week 8-9) and follow-up (week 12-13).
The WPAI is a self-report questionnaire that measures the impact of a specific health difficulty on work (e.g.
absenteeism, work productivity) and daily activities (e.g.
household chores, hobbies).
Higher scores on the WPAI indicate greater impact on work.
|
Week 8-9 and 12-13
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Test-Retest Reliability of the International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Time Frame: Week 0-1 (baseline) to week 1-2
|
Before the intervention begins, the IPAQ-SF will be completed at baseline (week 0-1) and 1-week later.
This will enable a reliability coefficient for the IPAQ-SF to be calculated for this population, which will later be used to calculate the Reliable Change Index (RCI) for participants.
|
Week 0-1 (baseline) to week 1-2
|
Collaborators and Investigators
Investigators
- Study Chair: Dr Fergal Jones, Canterbury Christ Church University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ETH2425-0016
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postmenopausal
-
YI-JU TSAIRecruitingMenopause | Postmenopausal | Postmenopausal DisorderTaiwan
-
Fundació EurecatCompletedMenopause | Postmenopausal Symptoms | Postmenopausal DisorderSpain
-
National Taiwan University HospitalRecruitingOsteoporosis | Osteoporosis PostmenopausalTaiwan
-
Hend HamdyNot yet recruiting
-
University of Erlangen-Nürnberg Medical SchoolElsbeth-Bonhoff-Stiftung, BerlinTerminatedPostmenopausalGermany
-
Warner ChilcottSanofiCompletedPostmenopausalUnited States, Poland, Canada, Croatia, Netherlands
-
Insel Gruppe AG, University Hospital BernRecruitingPostmenopausal | Postmenopausal FlushingSwitzerland
-
University of Arkansas, FayettevilleRecruiting
-
mAbxience Research S.L.CompletedPostmenopausal Women With OsteoporosisPoland, Serbia, Bulgaria, Georgia, Estonia, Hungary, Latvia, Mexico
-
Uskudar UniversityCompleted
Clinical Trials on Online Physical Activity Group
-
Istanbul UniversityCompletedObesity | Physical Activity | Exercise | Bariatric SurgeryTurkey
-
Rutgers, The State University of New JerseyTerminatedBreast Cancer | Resistance TrainingUnited States
-
California State University, East BayCompletedAphasia, AcquiredUnited States
-
Centro di Riferimento per l'Epidemiologia e la...Azienda Sanitaria Locale Torino 1CompletedBreast Cancer | Colorectal Cancer | Lifestyle Risk Reduction | Weight Changes, BodyItaly
-
Istanbul UniversityEnrolling by invitationPhysical Activity | Familial Mediterranean Fever | ExerciseTurkey
-
Universidad de CórdobaUnknown
-
Istanbul University - Cerrahpasa (IUC)Completed
-
University of New HampshireRecruitingObesity | Insulin Resistance | Impaired Glucose Tolerance | Metabolic DisturbanceUnited States
-
University of Nove de JulhoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.UnknownQuality of Life | PainBrazil
-
Université Sorbonne Paris NordLigue contre le cancer, France; Garmin International; StimulabRecruitingBreast Cancer | Lung Cancer | Prostate Cancer | Colo-rectal CancerFrance